Skip to content
OpenCapital
Get started

Twist Bioscience Corporation TWST EBITDA

EBITDA at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
——
Danaher logo
DanaherDHR
——
Agilent Technologies logo
Agilent TechnologiesA
——
Illumina logo
IlluminaILMN
——
TEC
Bio-TechneTECH
——
Revvity logo
RevvityRVTY
——

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Calculated from Twist Bioscience Corporation’s reported figures.

−$45.9Mebit+
$6.4MDepreciation Depletion & Amortization
=-$39.45M

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's EBITDA?
Twist Bioscience Corporation (TWST) reported EBITDA of -$39.45M in Q1 2026.
How has Twist Bioscience Corporation's EBITDA changed year-over-year?
Twist Bioscience Corporation's EBITDA decreased by 12.2% year-over-year, from -$35.16M to -$39.45M.
What is the long-term trend for Twist Bioscience Corporation's EBITDA?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's EBITDA has grown at a -6.0% compound annual growth rate (CAGR), from -$142.98M to -$111.41M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.